Esempio: Heart Attack

Cerca studi clinici per: Antiviral Agents

Totale 10767 risultati

NCT04513379

Non ancora reclutando

Efficacy of 400 mg Efavirenz Versus Standard 600 mg Dose in HIV/TB Co-infected Patients

Condizioni: HIV Infections; Tuberculosis
NCT04513626

Non ancora reclutando

Phase II Trial Evaluating the Capacity of the Dual Combination Doravirine/Raltegravir in HIV-1 Infected Patients Under a Current Antiretroviral Regimen

Condizioni: HIV Infections
NCT04513899

Non ancora reclutando

Development of a Community-based HCV Treatment Completion Intervention Among HCV Positive Homeless Adults

Condizioni: Hepatitis C Virus (HCV) Infection
NCT04509258

Non ancora reclutando

Effectiveness of N-acetyl Cysteine, Acetyl L- Carnitine and Medicated Paraffin Oil in Aluminium Phosphide Poisoning

Condizioni: the Study Focus to Improve the Standard of Care Used for Aluminuim Phosphide Poisoning and to Save Patients With the Minimal Organ Damage
NCT04509622

Non ancora reclutando

A Study of Oral Venetoclax Tablet in Combination With Subcutaneous Low-Dose Cytarabine (LDAC) Injection to Assess Adverse Events in Adult Japanese Participants With Acute Myeloid Leukemia (AML)

Condizioni: Acute Myeloid Leukemia (AML)
NCT04511039

Non ancora reclutando

Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer

Condizioni: Advanced Malignant Solid Neoplasm; Clinical Stage III Gastroesophageal Junction Adenocarcinoma; Clinical Stage IV Gastroesophageal Junction Adenocarcinoma; Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma; Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma A; Locally Advanced Colorectal Carcinoma; Locally Advanced Gastroesophageal Junction Adenocarcinoma; Metastatic Colorectal Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma; Pathologic Stage III Gastroesophageal Junction Adenocarcinoma; Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma; Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma; Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma; Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma; Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma; Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8; Stage III Colorectal Cancer AJCC v8; Stage IIIA Colorectal Cancer AJCC v8; Stage IIIB Colorectal Cancer AJCC v8; Stage IIIC Colorectal Cancer AJCC v8; Stage IV Colorectal Cancer AJCC v8; Stage IVA Colorectal Cancer AJCC v8; Stage IVB Colorectal Cancer AJCC v8; Stage IVC Colorectal Cancer AJCC v8
NCT04507269

Reclutamento

Study of VIR-2218 in Patients With Chronic Hepatitis B in Mainland China

Condizioni: Hepatitis B, Chronic
NCT04507607

Reclutamento

Efficacy and Safety of TAF in Pregnant Women With Chronic Hepatitis B Infection

Condizioni: Chronic Hepatitis B; Mother-to-child Block; Antiviral Treatment
NCT04504045

Non ancora reclutando

Metformin's Effect on Drug Metabolism in Patients With Type 2 Diabetes

Condizioni: Diabetes Mellitus, Type 2
NCT04501224

Non ancora reclutando

The Efficacy and Safety of TAF vs Other NAs in Patients With LVL

Condizioni: Chronic Hepatitis b; Cirrhosis Due to Hepatitis B
NCT04502342

Iscrizione su invito

Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients

Condizioni: Covid19
NCT04498936

Reclutamento

Sofosbuvir/Ledipasvir and Nitazoxanide for Treatment of COVID-19

Condizioni: COVID
NCT04499677

Non ancora reclutando

FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals

Condizioni: COVID-19
NCT04500418

Non ancora reclutando

Charité Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients

Condizioni: Covid19
NCT04500561

Non ancora reclutando

YY-20394 、GEMOX Treatment Diffuse Large B-cell Lymphoma Single Arm, Open, Multicentrized Phase 1b/2 Clinical Trial

Condizioni: Diffuse Large B Cell Lymphoma
NCT04500847

Non ancora reclutando

Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD

Condizioni: Alzheimer Disease, Early Onset; Mild Cognitive Impairment
NCT04497649

Reclutamento

Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients

Condizioni: Covid19
NCT04497883

Non ancora reclutando

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Maribavir Administered in Healthy Japanese Participants Compared With Matched, Healthy, Non-Hispanic, Caucasian Participants and to Assess Dose-Proportionality of 3 Doses of Maribavir in Japanese Participants

Condizioni: Healthy Volunteers
NCT04498689

Reclutamento

Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer

Condizioni: Metastatic Pancreatic Cancer
NCT04496882

Non ancora reclutando

Chronic Hepatitis b Patients Switch to tAf After Discontinuation of Nucleoside Analogue

Condizioni: Chronic Hepatitis b; Hepatitis B Reactivation
NCT04494399

Reclutamento

IFN Beta-1b and Ribavirin for Covid-19

Condizioni: Covid19
NCT04494412

Non ancora reclutando

An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection

Condizioni: Influenza, Human
NCT04495153

Non ancora reclutando

GMCI Plus Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC

Condizioni: Non Small Cell Lung Cancer
NCT04491942

Non ancora reclutando

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Condizioni: Advanced Bile Duct Carcinoma; Advanced Breast Carcinoma; Advanced Cervical Carcinoma; Advanced Endometrial Carcinoma; Advanced Esophageal Carcinoma; Advanced Gastric Carcinoma; Advanced Head and Neck Carcinoma; Advanced Lung Non-Small Cell Carcinoma; Advanced Lung Small Cell Carcinoma; Advanced Malignant Solid Neoplasm; Advanced Ovarian Carcinoma; Advanced Penile Carcinoma; Advanced Pleural Malignant Mesothelioma; Advanced Urothelial Carcinoma; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anatomic Stage IIIB Breast Cancer AJCC v8; Anatomic Stage IIIC Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Clinical Stage III Gastric Cancer AJCC v8; Clinical Stage IV Gastric Cancer AJCC v8; Clinical Stage IVA Gastric Cancer AJCC v8; Clinical Stage IVB Gastric Cancer AJCC v8; Pathologic Stage III Gastric Cancer AJCC v8; Pathologic Stage IIIA Gastric Cancer AJCC v8; Pathologic Stage IIIB Gastric Cancer AJCC v8; Pathologic Stage IIIC Gastric Cancer AJCC v8; Pathologic Stage IV Gastric Cancer AJCC v8; Prognostic Stage III Breast Cancer AJCC v8; Prognostic Stage IIIA Breast Cancer AJCC v8; Prognostic Stage IIIB Breast Cancer AJCC v8; Prognostic Stage IIIC Breast Cancer AJCC v8; Prognostic Stage IV Breast Cancer AJCC v8; Stage III Cervical Cancer AJCC v8; Stage III Distal Bile Duct Cancer AJCC v8; Stage III Intrahepatic Bile Duct Cancer AJCC v8; Stage III Lung Cancer AJCC v8; Stage III Ovarian Cancer AJCC v8; Stage III Penile Cancer AJCC v8; Stage III Pleural Malignant Mesothelioma AJCC v8; Stage IIIA Cervical Cancer AJCC v8; Stage IIIA Distal Bile Duct Cancer AJCC v8; Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIA Ovarian Cancer AJCC v8; Stage IIIA Penile Cancer AJCC v8; Stage IIIA Pleural Malignant Mesothelioma AJCC v8; Stage IIIA1 Ovarian Cancer AJCC v8; Stage IIIA2 Ovarian Cancer AJCC v8; Stage IIIB Cervical Cancer AJCC v8; Stage IIIB Distal Bile Duct Cancer AJCC v8; Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIB Ovarian Cancer AJCC v8; Stage IIIB Penile Cancer AJCC v8; Stage IIIB Pleural Malignant Mesothelioma AJCC v8; Stage IIIC Lung Cancer AJCC v8; Stage IIIC Ovarian Cancer AJCC v8; Stage IV Cervical Cancer AJCC v8; Stage IV Distal Bile Duct Cancer AJCC v8; Stage IV Intrahepatic Bile Duct Cancer AJCC v8; Stage IV Lung Cancer AJCC v8; Stage IV Ovarian Cancer AJCC v8; Stage IV Penile Cancer AJCC v8; Stage IV Pleural Malignant Mesothelioma AJCC v8; Stage IVA Cervical Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVA Ovarian Cancer AJCC v8; Stage IVB Cervical Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8; Stage IVB Ovarian Cancer AJCC v8; Triple-Negative Breast Carcinoma; Unresectable Urothelial Carcinoma
NCT04492475

Reclutamento

Adaptive COVID-19 Treatment Trial 3 (ACTT-3)

Condizioni: COVID-19
NCT04493164

Non ancora reclutando

Phase II Investigator Sponsored Study of CPX-351 in Combination With Ivosidenib for Patients With IDH1 Mutated Acute Myeloid Leukemia or High-Risk MDS.

Condizioni: Acute Myeloid Leukemia; Acute Myeloid Leukemia With Gene Mutations; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia
NCT04493216

Non ancora reclutando

A Dose-Range Finding Clinical Trial Study in Human Immunodeficiency Virus (HIV-1) Infected Treatment-Naive Adults

Condizioni: HIV Infections
NCT04488926

Reclutamento

Micronized and Ultramicronized Palmitoylethanolamide in Fibromyalgia Patients

Condizioni: Fibromyalgia
NCT04489173

Non ancora reclutando

TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer

Condizioni: Breast Neoplasm; Chemotherapy Effect
NCT04489732

Non ancora reclutando

MSCs for Radiation-induced Xerostomia

Condizioni: Xerostomia Following Radiotherapy
NCT04488081

Reclutamento

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Condizioni: COVID-19
NCT04485039

Non ancora reclutando

Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders

Condizioni: Smallpox
NCT04483674

Non ancora reclutando

Bictegravir/FTC/TAF for the Treatment of Primary HIV Infection

Condizioni: HIV Primary Infection
NCT04483960

Reclutamento

Australasian COVID-19 Trial (ASCOT)

Condizioni: SARS-CoV-2 Infection (COVID-19)
NCT04481009

Non ancora reclutando

A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors

Condizioni: Advanced Solid Tumors
NCT04481035

Attivo, non reclutamento

Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1

Condizioni: Neurofibromatosis 1
NCT04481048

Non ancora reclutando

Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1

Condizioni: Neurofibromatosis 1
NCT04481204

Non ancora reclutando

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

Condizioni: Borderline Resectable Pancreatic Adenocarcinoma; Locally Advanced Pancreatic Ductal Adenocarcinoma; Resectable Pancreatic Ductal Adenocarcinoma
NCT04481802

Non ancora reclutando

The Effect of RadiaAce Gel in the Prevention and Treatment of Radiation Dermatitis in Breast Cancer Patients

Condizioni: Breast Cancer; Radiation Dermatitis
NCT04481945

Non ancora reclutando

Evaluation of Antimicrobial Efficacy and Adaptability of Bioceramic Sealer Containing Nanoparticles

Condizioni: Endodontic Disease
NCT04479202

Completato

The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19

Condizioni: Berberine; COVID-19
NCT04480138

Reclutamento

Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19)

Condizioni: Covid19
NCT04480190

Non ancora reclutando

Neoadjuvant Therapy in Biliary Adenocarcinoma

Condizioni: Cholangiocarcinoma; Biliary Cancer
NCT04480268

Reclutamento

PAXG Out in the Country

Condizioni: Pancreatic Ductal Adenocarcinoma
NCT04480333

Reclutamento

Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831

Condizioni: Covid19; Corona Virus Infection; Severe Acute Respiratory Syndrome; Severe Acute Respiratory Infection; Severe Acute Respiratory Syndrome (SARS) Pneumonia; Severe Acute Respiratory Syndrome of Upper Respiratory Tract; Neurodegeneration; Neuroinflammatory Response
NCT04480372

Non ancora reclutando

SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

Condizioni: Malignant Pleural Mesothelioma; Non-small Cell Lung Cancer
NCT04480593

Reclutamento

The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19.

Condizioni: Covid19
NCT04480736

Reclutamento

A Study of JNJ-64281802 Against Dengue Serotype 1 Infection in a Dengue Human Challenge Model in Healthy Adult Participants

Condizioni: Healthy
NCT04476186

Reclutamento

The Effectiveness of Oral Acyclovir in the Treatment of Molluscum Contagiosum in Children

Condizioni: Molluscum Contagiosum
NCT04476719

Attivo, non reclutamento

The Bioequivalence Study of Umifenovir 200 mg Capsul (ATABAY, Turkey) Under Fasting Conditions

Condizioni: Bioequivalence